Shares of Unity Software Inc. (U) have gained 3.4% over the past four weeks to close the last trading session at $20.66, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any …
Shares of Adaptive Biotechnologies (ADPT) have gained 5.1% over the past four weeks to close the last trading session at $8.81, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. …
Clearway Energy (CWEN) closed the last trading session at $28.61, gaining 2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target …
Novo Nordisk (NVO) closed the last trading session at $67.55, gaining 3.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target …
Pfizer (PFE) closed the last trading session at $22.79, gaining 1.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of …
BioCryst Pharmaceuticals (BCRX) closed the last trading session at $10.08, gaining 48.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target …
We recently published a list of Billionaire Louis Bacon’s 10 Stock Picks with Huge Upside Potential. In this article, we are going to take a look at where ConocoPhillips (NYSE:COP) stands against other stock picks with huge upside potential. Louis Moore Bacon is the …
Ironwood Pharmaceuticals IRWD reported an adjusted loss of 14 cents per share for the first quarter of 2025, which was wider than the Zacks Consensus Estimate of a loss of 5 cents. The company had reported an adjusted loss of 2 cents per share …
Medication company Viatris (NASDAQ:VTRS) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 11.2% year on year to $3.25 billion. The company’s full-year revenue guidance of $13.75 billion at the midpoint came in 0.5% below analysts’ estimates. Its non-GAAP profit …
Manulife Financial Corporation MFC delivered first-quarter 2025 core earnings of 69 cents per share, which missed the Zacks Consensus Estimate by 1.4%. The bottom line decreased 1.4% year over year. Core earnings of $1.2 billion (C$1.8 billion) declined 7.6% year over year. Core earnings …